Cargando…
Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation
The development of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines has been a significant accomplishment. Adverse events are extremely rare, but continued surveillance is important, especially in at-risk populations. In 5 patients with preexisting...
Autores principales: | Rocco, Joseph M, Mallarino-Haeger, Christina, Randolph, Attiya H, Ray, Susan M, Schechter, Marcos C, Zerbe, Christa S, Holland, Steven M, Sereti, Irini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689836/ https://www.ncbi.nlm.nih.gov/pubmed/34893818 http://dx.doi.org/10.1093/cid/ciab1024 |
Ejemplares similares
-
Drugs for paediatric hyperinflammatory syndromes
por: Hon, Kam Lun, et al.
Publicado: (2022) -
Haemophagocytic lymphohisticytosis—an underrecognized hyperinflammatory syndrome
por: Hutchinson, Matthew, et al.
Publicado: (2019) -
Infection-Triggered Hyperinflammatory Syndromes in Children
por: Rossano, Martina, et al.
Publicado: (2022) -
Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020) -
2701. Mycobacterial Immune Reconstitution Inflammatory Syndrome Following Hematopoietic Cell Transplantation for GATA2 Deficiency
por: Epling, Brian P, et al.
Publicado: (2023)